Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies
Clinical trial NCT02961101 · RECRUITING
Trial details
- NCT number
- NCT02961101
- Sponsor
- Han weidong
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2026-05-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.